Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
167.8 USD
-1.03%
Market Closed
Updated:
Apr 25, 2024
Abbvie Inc
Other Long-Term Assets
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Other Long-Term Assets Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Long-Term Assets
$8.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
48%
|
CAGR 10-Years
27%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Long-Term Assets
$4.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Long-Term Assets
$9.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Long-Term Assets
$2.6B
|
CAGR 3-Years
42%
|
CAGR 5-Years
11%
|
CAGR 10-Years
97%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Long-Term Assets
$2.9B
|
CAGR 3-Years
45%
|
CAGR 5-Years
26%
|
CAGR 10-Years
29%
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Long-Term Assets
$100.1m
|
CAGR 3-Years
79%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
34%
|
See Also
What is Abbvie Inc's Other Long-Term Assets?
Other Long-Term Assets
8.5B
USD
8.5B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Long-Term Assets amounts to 8.5B USD.
What is Abbvie Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
27%
27%
Over the last year, the Other Long-Term Assets growth was 53%. The average annual Other Long-Term Assets growth rates for Abbvie Inc have been 21% over the past three years , 48% over the past five years , and 27% over the past ten years .
You don't have any saved screeners yet
